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Abstract
Background: Up to 20% of all infective endocarditis are blood culture-negative and therefore a diagnostic challenge.
Here we present the case of an infective endocarditis due to Helicobacter cinaedi finally diagnosed using different
molecular methods. This highly fastidious gram-negative spiral rod is increasingly recognized as a human pathogen,
above all in immunocompromised patients. So far H. cinaedi has been associated with bacteremia, cellulitis, arthritis
and meningitis.
Case presentation: A 71-year-old man presented with fever and progressive dyspnea for weeks. He was
immunocompromised by long-term steroid therapy. As one major and two minor Duke’s criteria (vegetation, fever
and aortic valve stenosis as predisposition) were present, an infective endocarditis was suspected and an empiric
therapy with amoxicillin/clavulanic acid and gentamicin was established. The persistent severe aortic regurgitation
resulted in a valve replacement. Histological evaluation of the aortic valve showed a polypous-ulcerative endocarditis.
Gram stain and culture remained negative. Broad-range bacterial PCR targeting the 16S rRNA gene on the biopsy of
the aortic valve identified H. cinaedi as the causative agent. The antibiotic therapy was simplified accordingly to
ceftriaxone and gentamicin with a recommended duration of 6 weeks. Ten days after valve replacement the
patient was discharged. To complete our molecular finding, we sequenced nearly the complete 16S rRNA gene
(accession number KF914917) resulting in 99.9% identity with H. cinaedi reference sequences. Based on this result, 2
species-specific PCR tests amplifying part of the ctd gene were established and applied to the valve specimen. The 2
PCRs confirmed H. cinaedi. In addition, we analyzed stool, urine and saliva from the patient using H. cinaedi PCR. The
fecal and urine specimen showed a positive signal, saliva was PCR-negative.
Conclusion: We identified H. cinaedi as causative agent of a culture-negative endocarditis in an immunocompromised
patient using broad-range and specific PCR. In addition to 2 cases from Japan presented on international meetings in
2010 and 2013, our case report shows that H. cinaedi should be recognized as additional causative organism of infective
endocarditis. The use of molecular diagnostic techniques proved to be a powerful complement for the detection of
blood culture-negative infective endocarditis.
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Background
Helicobacter cinaedi is a spiral-shaped gram-negative
rod, previously named Campylobacter cinaedi and was
transferred to the genus Helicobacter in 1991 based on
molecular phylogenetic analyses [1]. First detected from
rectal swabs in homosexual men in 1984, H. cinaedi is
considered an enterohepatic colonizer of the lower gastro-
intestinal tract of numerous mammals [2]. H. cinaedi is
increasingly recognized as a human pathogen, and has
been isolated from both immunocompetent [3] and from
immunocompromised [4,5] patients. So far, cases of
bacteremia [5-7], gastroenteritis [8], cellulitis [3,4], arthritis
[9], meningitis [10], myopericarditis [11] and infections in
asplenic patients have been reported [12]. H. cinaedi is ex-
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The microaerophilic bacterium appears on agar plates
as swarming thin film and should be preferably stained
with acridine orange and not using Gram staining [13].
In a very recent study, Araoka H. et al. [6] showed that
45% of blood cultures showed growth with H. cinaedi
only after >5 days of incubation.
Case presentation
A 71-year-old man presented to the emergency room of
a district hospital with progressive dyspnea. He reported
experiencing fatigue, recurrent chills and fever spikes for
several weeks. In his medical history was a polymyalgia
rheumatica treated with long-term steroids (15 mg/d) and
a moderate aortic stenosis. On admission, the patient was
afebrile (37.2°C), tachycard (118/min.) and tachypnoeic
(40/min.) with a blood pressure of 125/55 mmHg. There
were bibasilar crackles on lung auscultation and cardiac
examination revealed a 3/6 systolic and a 2/6 diastolic
murmur. Laboratory analysis showed a leukocytosis of
21.2 G/l (range 3.5-10 G/l), an elevated C-reactive protein
of 54 mg/l (<5 mg/l) and a creatinine level of 123 μmol/l
(range 49–97 μmol/l). A pulmonary edema due to acute
heart failure was diagnosed, and the patient had to be
transferred to the intensive care unit for respiratory non-
invasive ventilation. A transesophageal echocardiography
(TEE) showed a thickened left coronary cusp with several
mobile structures on its surface, together with a concomi-
tant aortic regurgitation. There was no evidence of a peri-
valvular abscess. According to the modified Duke’s criteria
[14] one major criterion (vegetation on the aortic valve)
and two minor criteria (fever and aortic valve stenosis as a
predisposition) were present, leading to the diagnosis of
a possible infective endocarditis (IE). Therefore, an em-
piric intravenous antibiotic treatment with amoxicillin/
clavulanic acid (2.2 g every 4 hours) and gentamicin
(70 mg every 8 hours) was started. Subsequently, fever
decreased but all blood cultures remained negative des-
pite the fact that they had been taken before starting
antibiotic therapy. Eight days after admission, the pa-
tient was transferred to our tertiary-care hospital for an
urgent valve replacement because of deteriorating heart
failure. Intra-operatively, a large aortic vegetation attached
to the left coronary cusp and an abscess cavity with de-
struction of the cusp and aortic root were seen. A Mini-
Root replacement with a Freestyle Aortic Root Heart
Valve and an annuloplasty to repair the mitral valve was
performed. Post-operatively the patient developed a third-
degree atrio-ventricular block, necessitating the implant-
ation of a pacemaker.
Histology of the aortic valve showed a polypous-
ulcerative endocarditis but Gram stain and conventional
aerobic and anaerobic culture remained negative. Finally,
broad-range bacterial PCR targeting the first half of the
16S rRNA gene on the fresh resected aortic valve identified
H. cinaedi as the causative agent [15]. To complete our
molecular finding, we amplified and sequenced nearly the
complete 16S rRNA gene and submitted the 1458-bp-long
sequence to the GenBank data base (accession no.
KF914917). Comparison to H. cinaedi reference sequences
resulted in a one-nucleotide difference (99.9% similarity)
to reference strain PAGU0626 (accession no. AB275328)
and 5 further H. cinaedi strains published in 2007 [3]. In
addition, we established 2 species-specific PCR tests amp-
lifying part of the cytolethal distending toxin gene (ctd)
based on the study of Oyama K et al. [16] and applied
them to the fresh as well as to the formalin-fixed paraffin-
embedded (FFPE) valve specimen. Deparaffinization of the
FFPE specimen was done using a xylol incubation step,
then the fresh and dried FFPE sample were extracted with
the QIAamp Mini Kit (Qiagen). The 2 independent PCRs
including sequencing of the PCR amplicons confirmed the
detection of H. cinaedi in both specimens (Figure 1).
Sequence analysis of unspecific PCR products (approx.
850 bp) from the biopsy extracts of PCR 1 assay resulted
in human DNA. The negative PCR result from the FFPE
specimen in PCR 1 (expected fragment length 659 bp)
could be explained by degradation or crosslinking of the
DNA by formalin. Furthermore, we collected stool, urine
and saliva from the patient 3 weeks after valve replacement
and analyzed the 3 samples using nested H. cinaedi PCR
combining the 2 PCR assays mentioned above according
to [16]. The fecal and urine specimen showed a positive
signal only after reamplification, saliva was PCR-negative.
Having confirmed H. cinaedi as the causative agent of
IE, completion of treatment with amoxicillin 2 g every
H.cinaedi PCR1 H.cinaedi PCR2
L 1 2 3 4 5 6 7 8 9 10[bp]
Figure 1 Conventional 40-cycle Helicobacter cinaedi PCR 1 and
2 targeting the cdt gene resulting in 659-bp and 359-bp
amplicons, respectively. Polyacrylamid-based gel electrophoresis
of PCR products using Agilent 2200 Tape Station (Agilent Technologies).
L, molecular weight ladder; lane 1 and 6, 400 ng DNA of aortic valve
(formalin-fixed); lane 2 and 7, 80 ng DNA of aortic valve (formalin-fixed);
lane 3 and 8, 250 ng DNA of aortic valve (fresh); lane 4 and 9,
50 ng DNA of aortic valve (fresh); lane 5 and 10, negative control
(5 μl of elution buffer).
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4 hours was suggested. Unfortunately, the patient did not
tolerate this therapy. Therefore, we had to change the anti-
biotic treatment to ceftriaxone 2 g in combination with
gentamicin 180 mg every 24 hours. A treatment duration
of six weeks after valve replacement was recommended.
On day ten after valve replacement the patient was dis-
charged in a rehabilitation clinic. Over time, the patient’s
condition gradually improved and the inflammation par-
ameter normalized. Five weeks after cardiac surgery and
six weeks after start of antibiotic treatment, the patient
discontinued intravenous antibiotic therapy against med-
ical advice because of non-hazardous adverse events. In a
follow up examination six weeks after cessation of therapy
the patient presented still in good clinical condition with
normal inflammation parameters. So far, no evidence for
recurrence was found, however long term follow up is
pending.
To our knowledge, this is the first published case of an
infective endocarditis with H. cinaedi. Additional cases
of IE associated with H. cinaedi have been described
in two abstracts presented at international conferences
[17,18]. Taking into account these further cases, the clinical
significance of H. cinaedi in invasive infections such as IE
should be taken seriously. Moreover, H. cinaedi could be
considered as an additional causative pathogen of IE, espe-
cially in cases of culture-negative IE.
Up to 20% of all IE remain blood-culture negative
[19,20] and are therefore still a diagnostic and therapeutic
challenge. Beside antibiotic pre-treatment, one of the most
common reasons for culture-negative IE are infections
with obligate intracellular or fastidious organisms [19].
Due to the highly fastidious characteristics of Helicobacter
species, independent molecular tests represent powerful
alternatives to detect and identify these organisms. In the
reported case, all blood cultures and the conventional cul-
tures of the resected valve remained negative, even though
the diagnosis of infective endocarditis was definitely dem-
onstrated by histologic examination and intra-operatively
described intra-cardiac abscess. Only broad-range bacterial
PCR of the biopsy of the aortic valve and species-specific
PCR of purified DNA from the histological specimen iden-
tified H. cinaedi as the causative agent. This case highlights
the importance of alternative diagnostic approaches like
PCR and sequence analysis (e.g. bacterial broad-range PCR
targeting the 16S rRNA gene) for microbiological diagno-
sis, particularly for IE.
The detection of H. cinaedi DNA from stool and urine
samples 3 weeks after initiating antimicrobial treatment
is in congruency to the data of Oyama K. et al. [16], de-
scribing patients with fever and/or cellulitis. This find-
ings may further indicate colonization of H. cinaedi in
the enterohepatic tract.
A disadvantage of the molecular techniques is the lack
of antimicrobial susceptibility testing. In the reported case,
valve replacement and intravenous antibiotic treatment
with amoxicillin/clavulanic acid followed by a combination
of gentamicin and ceftriaxone, showed a successful clinical
response and outcome. This antibiotic treatment is in
accordance with previously published cases of invasive
infections with H. cinaedi, where culture and therefore
microbiologic resistance testing was available [4,5]. An
epidemiologic study of 23 patients with H. cinaedi–
associated illness by Kiehlbauch JA et al. [4] reported that
treatment with a penicillin, tetracycline, or aminoglycoside
may be more effective than treatment with cephalosporins,
erythromycin, or ciprofloxacin. In particular, isolates
can be resistant against quinolones. Nevertheless, scant
data on treatment of infections with H. cinaedi has been
published. The additional cases of IE due to H. cinaedi
mentioned above were treated with a combined antibiotic
therapy consisting of ampicillin/gentamicin [18] and cef-
triaxone followed by levofloxacin [17]. There are no exist-
ing guidelines for choice or for duration of antibiotic
treatment in cases of IE with H. cinaedi. Since recurrent
infections are described [5], prolonged and combined anti-
biotic treatment is recommended.
Conclusions
We identified H. cinaedi as a causative agent of a
culture-negative endocarditis in an immunocompromised
patient using broad-range bacterial (16S rRNA gene) and
specific (ctd gene) PCR. In addition to two cases from
Japan presented at international meetings in 2010 and
2013 [17,18], our case report shows that H. cinaedi should
be recognized as an additional causative organism of IE.
The use of molecular techniques proved to be a powerful
diagnostic adjunct for blood culture-negative IE.
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